Abstract 2917: Antitumor effects of an epigenetic inhibitor, 4SC-202, on human osteosarcoma cells
Torres, Haydee Magdalena, Van Cleave, Ashley, Palmer, Mykayla, Callahan, Dakota, Smithback, Austyn, May, Danielle, Roux, Kyle, Tao, Jianning
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 2755: Defining the properties of the OS-33 osteosarcoma cell line and the effects of mTORC1 inhibition by rapamycin treatment
VanCleave, Ashley, Palmer, Mykayla, Fang, Fang, Torres, Haydee M., Ross, Alan, Lieferman, Patricia Crotwell, Tecleab, Yohannes, Houghton, Peter J., Tao, Jianning
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway
VanCleave, Ashley, Palmer, Mykayla, Fang, Fang, Torres, Haydee, Rodezno, Tania, Li, Qilin, Fuglsby, Kirby, Evans, Claire, Afeworki, Yohannes, Ross, Alan, Rao, Pulivarthi, Leiferman, Patricia, Zheng, Siyuan, Houghton, Peter, Tao, Jianning
Published in Oncotarget (07.07.2020)
Published in Oncotarget (07.07.2020)
Get full text
Journal Article